摘要
恶性黑色素瘤(MM)是一种由皮肤和其他器官的黑素细胞产生的肿瘤。其恶性程度高,易局部复发和远处转移,预后差。MM的治疗选择在过去十年发生了巨大的变化,但目前临床仍缺乏有效的治疗手段,国内外尚无统一的治疗标准,近年免疫、靶向治疗成为MM患者改善预后的新方案。故本文探讨了MM的各种免疫、靶向治疗及联合治疗的最新研究成果。
Malignant melanoma(MM)is a tumor produced by melanocytes in the skin and other organs.Which has the characteristics of high degree of malignancy,easy local recurrence and distant metastasis,and is poor prognosis.The treatment options for MM have undergone tremendous changes in the past decade,but there is still lack of effective treatment methods in clinical practice,and there is no unified treatment standard at home and abroad.In recent years,immunization and targeted therapy have become new options for improving the prognosis of MM patients.Therefore,this article discussed the latest research results of various immune,targeted therapy and combination therapy of MM.
作者
毛爱迪(综述)
陈爱军
王萍(审校)
MAO Aidi;CHEN Aijun;WANG Ping(Department of Dermatology,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)
出处
《重庆医学》
CAS
2021年第20期3581-3585,共5页
Chongqing medicine
关键词
恶性黑色素瘤
免疫治疗
靶向治疗
联合治疗
综述
malignant melanoma
immunotherapy
targeted therapy
combination therapy
review
